comparemela.com

Latest Breaking News On - Adding that - Page 4 : comparemela.com

China condemns violence in Solomon Islands: FM spokesperson

1st LD: Xi eyes greater development of ties with Dominican Republic

1st LD: Xi eyes greater development of ties with Dominican Republic Xinhua 03 Jun 2021, 04:44 GMT+10 BEIJING, June 2 (Xinhua) Chinese President Xi Jinping said Wednesday that China stands ready to work with the Dominican Republic to steer their relationship towards greater development and continuously lift it to higher levels. Xi made the remarks in a telephone conversation with Luis Abinader, president of the Dominican Republic. Noting that since the two countries established diplomatic ties, the Dominican Republic has firmly adhered to the one-China policy and made relations with China a priority in foreign policy, Xi said China highly appreciates that. Since the outbreak of the COVID-19 pandemic, the two countries have stood together and supported each other, Xi said, adding that China will continue to provide as much support as it can for the Dominican Republic s fight against the coronavirus.

Cambodia s COVID-19 death toll nears 100 after report of 3 new fatalities

COMP SERVICES (CMPS), FIELD TRIP HEALTH LTD by Field Trip Health Ltd (FTRPF), Greenstar Biosciences (GTSIF), Johnson & Johnson (JNJ), NUMINUS WELLNESS INC by NUMINUS WELLNESS INC (LKYSD), MIND MEDICINE MINDMED by MIND MEDICINE MINDMED INC (MMEDF), MYDECINE INNOV GRP by MYDECINE INNOVATIONS GROUP INC (MYCOF), Red White & Bloom Brands (RWBYF) - Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week

Significant Progress Made as Numinus-Sponsored PRIME Study on Psilocybin-Assisted Psychotherapy for Opioid, Stimulant and/or Alcohol Use Disorders Enters Pre-Implementation Stage Numinus Wellness (OTC:LKYSD) and  Syreon Corporation, a global contract research organization with expertise in conducting clinical trials across a broad range of diseases, are pleased to share that significant progress has been made in the single-arm, open-label compassionate access1 trial of Psilocybin-Research Intervention with Motivational Enhancement (PRIME) for substance use disorders. The study will contribute to a growing body of research to inform larger randomized controlled trials for these indications. The study will take place in Vancouver and will enroll 30 individuals with opioid, stimulant and/or alcohol use disorders. Syreon is leading the trial as Clinical Research Organization (CRO) with Numinus as the trial sponsor.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.